Ownership history in Eversept Partners, LP · 12 quarters on record
This page tracks every 13F SEC filing in which Eversept Partners, LP reported a position in VAXCYTE INC (PCVX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 1,197,722 | -224,261 | -15.8% | 2.78% | $55.3M | $46.14 |
| 2025 Q3 | ADDED | 1,421,983 | +123,469 | +9.5% | 3.53% | $51.2M | $36.02 |
| 2025 Q2 | ADDED | 1,298,514 | +741,444 | +133.1% | 3.88% | $42.2M | $32.51 |
| 2025 Q1 | ADDED | 557,070 | +429,482 | +336.6% | 2.14% | $21.0M | $37.76 |
| 2024 Q4 | ADDED | 127,588 | +31,499 | +32.8% | 0.93% | $10.4M | $81.86 |
| 2024 Q2 | REDUCED | 96,089 | -101,242 | -51.3% | 0.50% | $7.3M | $75.51 |
| 2024 Q1 | REDUCED | 197,331 | -36,508 | -15.6% | 0.90% | $13.5M | $68.31 |
| 2023 Q4 | ADDED | 233,839 | +43,409 | +22.8% | 1.29% | $14.7M | $62.80 |
| 2023 Q3 | REDUCED | 190,430 | -5,261 | -2.7% | 0.82% | $9.7M | $50.98 |
| 2023 Q2 | REDUCED | 195,691 | -103,359 | -34.6% | 1.01% | $9.8M | $49.94 |
As of 2025 Q4 — sorted by position size